ReviewClinical pharmacokinetics2014

Clinical pharmacokinetics and pharmacodynamics of the novel SGLT2 inhibitor ipragliflozin.

Takeshi Kadokura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.